ASCO® 2026 Highlights: Presenter Vignette – Lili Mao

Dr. Lili Mao

Lili Mao

MD

Peking University Cancer Hospital

9516

Cadonilimab or ivonescimab plus axitinib in metastatic mucosal melanoma: Results from a phase Ib trial.